THE AUSTRIAN CENTRE
OF INDUSTRIAL BIOTECHNOLOGY

acib ist ein internationales Kompetenzzentrum für industrielle Biotechnologie. Das Zentrum entwickelt neue, umweltfreundliche und wirtschaftlich sowie technisch fortschrittliche Prozesse für die Biotech-, Pharma- und chemische Industrie – und nimmt sich dabei die Methoden der Natur zum Vorbild. acib verbindet anwendungsorientierte Forschung mit produzierender Industrie. Partner des acib-Netzwerkes profitieren vom umfassenden vorhandenen Knowhow sowie von modernster Infrastruktur, was eine rasche Umsetzung wissenschaftlicher Ergebnisse in konkrete Prozesse und Produkte ermöglicht. Das acib-Netzwerk bietet zugeschnittene Lösungen für Stakeholder aus Forschung, Industrie und Investment.

 NEUESTE BLOG ARTIKEL
  • When biotechnologists follow their noses
  • How microbiome studies can provide the basis to reduce food waste
  • Das Hefe-Orchester und seine Werke
  • Carbon dioxide in a circular economy
  • Time for real-time monitoring of biopharma production
  • Open innovation – a case of „nothing ventured, nothing gained“
  • Gene switch in yeast discovered
  • Computer aided design of separation processes  in pharmaceutical production
  • Getting more oxygen into your system – an innovative way of process intensification
  • Glycobiology meets chemistry to generate tailor-made offspring
  • When biotechnologists follow their noses

    It is grey, waxy, smelly and very expensive: Ambra, the worlds rarest organic substance, could only be found in the digestive tract of sperm whales. The compound is highly sought after by the perfume industry due to its fragrance fixative properties and distinctive aroma. Biotechnologists found a new biosynthetic pathway to produce the precursor of Ambra, names Ambrein, exactly as it occurs in nature. The findings could revolutionize the perfume industry by making different products eco-friendly.

    Read more

  • How microbiome studies can provide the basis to reduce food waste

    Plants, which are the primary source of food and animal feed, are not only affected by diseases during their growth but also following harvest and subsequent storage. Especially fungi that can efficiently degrade organic matter cause substantial losses of this valuable resource. Such losses can be prevented if adequate countermeasures are implemented. A recent study demonstrates how microbial markers can be used for the early detection of disease progression. Reliable biomarkers can be specifically targeted in the future to reduce food waste and to improve the storability of agricultural goods.

    Read more

  • Das Hefe-Orchester und seine Werke

    Enzymes are playing the first violin, the cell is hosting a perfectly coordinated orchestra and reserachers are the composers? Instead of sounds they produce fragrances? Our musical thought experiment demonstrates the complex production processes of biotechnology with aromatics as an example.

    Read more

  • Carbon dioxide in a circular economy

    Carbon dioxide (CO2) emission is a massive problem for our climate; this is well-known. We urgently need measures to prevent earth from the big collapse. Where do we find them? Biotechnology offers some interesting solutions.

    Read more

  • Time for real-time monitoring of biopharma production

    While currently most production processes for biopharmaceuticals are assessed by laboriuos and time-consuming off-line analytics, a new process enables the monitoring of such processes in real-time. Sensors  combined with  mathematical models deliver information on the quality and quantity of the product, as well as on content and profile impurities. This allows an instant monitoring of processes, making processes safer, faster, cheaper and more efficient.

    Read more

  • Open innovation – a case of „nothing ventured, nothing gained“

    The modern business world is using a new buzzword: “Open innovation”. What does it mean? How “open” do we need to be? What could be the benefit? And what does it look like in reality?

    Read more

  • Gene switch in yeast discovered

    Scientists from the Department of Biotechnology at the University of Natural Resources and Life Sciences (BOKU) Vienna and the Austrian Centre of Industrial Biotechnology (acib) discovered a gene switch in yeast, that was able to change twelve genes – and thereby the metabolic process of yeast as a whole. This work explains evolutionary events that happened more than 120 million years ago. The results have recently been published in the scientific journal Nature Communications and have the potential to be used in the food and feed industry and for the production of bio fuels and new building blocks for bioplastics.

    Read more

  • Computer aided design of separation processes in pharmaceutical production

    Have you ever thought about how drugs are manufactured? They are often produced by microorganisms which secret them into their environment: a soup of media, the target drug and waste that must be eliminated. In the pharmaceutical industry, people use chromatography columns to purify the medication. This process is used for more than a century for the separation of compounds. One may think that everything should be already known for such a well-established process. Yet, acib researchers found out recently that already the connecting tubes and valves affect the quality of the separation process and – in the end – product quality.

    Read more

  • Getting more oxygen into your system – an innovative way of process intensification

    More efficiency, more quality, more process safety, less costs, less waste – these are the target specifications of each and every production process in chemical industry. It seems quite ambitious to meet all these requirements, but a new key word has entered the engineering world: process intensification!

    Read more

  • Glycobiology meets chemistry to generate tailor-made offspring

    An interdisciplinary team of scientists is pioneering the development of synthetic glycobiology and trains 15 young researchers in the enabling technologies that underpin the development and exploitation of glycoscience: An exciting topic that promises to bring innovative solutions for the future!

    Read more

FÖRDERGEBER UND EIGENTÜMER

Das acib ist eine industrieorientierte Non-Profit Organisation nach öffentlichem Recht. Eigentümer des acib sind:

K2-KOMPETENZZENTRUM

acib ist ein internationales Kompetenzzentrum für industrielle Biotechnologie. Das Zentrum entwickelt neue, umweltfreundliche und wirtschaftlich sowie technisch fortschrittliche Prozesse für die Biotech-, Pharma- und chemische Industrie – und nimmt sich dabei die Methoden der Natur zum Vorbild. acib verbindet anwendungsorientierte Forschung mit produzierender Industrie. Partner des acib-Netzwerkes profitieren vom umfassenden vorhandenen Knowhow sowie von modernster Infrastruktur, was eine rasche Umsetzung wissenschaftlicher Ergebnisse in konkrete Prozesse und Produkte ermöglicht. Das acib-Netzwerk bietet zugeschnittene Lösungen für Stakeholder aus Forschung, Industrie und Investment.

Mehr über COMET



Innovations from Nature 1
Innovations from Nature 4
Innovations from Nature 5
Innovations from Nature 2
Innovations from Nature 3
Innovations from Nature 6